Cargando…
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
Astatine-211-parthanatine ([(211)At]PTT) is an alpha-emitting radiopharmaceutical therapeutic that targets poly(adenosine-diphosphate-ribose) polymerase 1 (PARP1) in cancer cells. High-risk neuroblastomas exhibit among the highest PARP1 expression across solid tumors. In this study, we evaluated the...
Autores principales: | Makvandi, Mehran, Samanta, Minu, Martorano, Paul, Lee, Hwan, Gitto, Sarah B., Patel, Khushbu, Groff, David, Pogoriler, Jennifer, Martinez, Daniel, Riad, Aladdin, Dabagian, Hannah, Zaleski, Michael, Taghvaee, Tara, Xu, Kuiying, Lee, Ji Youn, Hou, Catherine, Farrel, Alvin, Batra, Vandana, Carlin, Sean D., Powell, Daniel J., Mach, Robert H., Pryma, Daniel A., Maris, John M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671962/ https://www.ncbi.nlm.nih.gov/pubmed/36396952 http://dx.doi.org/10.1038/s42003-022-04209-8 |
Ejemplares similares
-
Preclinical Development of [(211)At]meta- astatobenzylguanidine ([(211)At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
por: Batra, Vandana, et al.
Publicado: (2022) -
PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response
por: Riad, Aladdin, et al.
Publicado: (2020) -
Realizing Clinical Trials with Astatine-211: The Chemistry Infrastructure
por: Lindegren, Sture, et al.
Publicado: (2020) -
Targeted radionuclide therapy with astatine-211: Oxidative dehalogenation of astatobenzoate conjugates
por: Teze, David, et al.
Publicado: (2017) -
Simulation of the distribution of astatine-211 solution dispersion in a lab room
por: Kubo, Hitoshi, et al.
Publicado: (2021)